ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 1417

Back to Feeling Normal Again: Patients with Rheumatoid Arthritis in Remission

Linda Rasch1, Maarten Boers2,3, Willem F. Lems1,2, Samina Turk4, Dirkjan van Schaardenburg2,5, Tessa Sanderson6, Sarah Hewlett6 and Lilian van Tuyl1, 1Amsterdam Rheumatology and immunology Center | VU University Medical Center, Amsterdam, Netherlands, Amsterdam, Netherlands, 2Amsterdam Rheumatology and immunology Center | Reade, Amsterdam, Netherlands, Amsterdam, Netherlands, 3Epidemiology & Biostatistics, VU University Medical Center, Amsterdam, Netherlands, Amsterdam, Netherlands, 4Rheumatology, Amsterdam Rheumatology and immunology Center | Reade, Amsterdam, Netherlands, Amsterdam, Netherlands, 5Clinical Immunology & Rheumatology F4.105, Amsterdam Rheumatology and immunology Center | Academic Medical Center, Amsterdam, Netherlands, Amsterdam, Netherlands, 6Nursing and Midwifery, University of the West of England, Bristol, United Kingdom, Bristol, United Kingdom

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: PRO, remission and rheumatoid arthritis (RA)

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 14, 2016

Session Title: Quality Measures and Quality of Care - Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: The American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) definition of remission in rheumatoid arthritis (RA) [1] lacks information on patient perceived remission [2]. Qualitative research identified ‘returning back to normal’ as one of three themes of patient perceived remission [3]. A questionnaire to measure this ‘normality’ was developed in Bristol and investigated for its discriminative ability [4].

Objectives: This study investigated the relationship between patient perceived concepts of normality and remission, and the ability of the normality questionnaire to discriminate between remission and non-remission states.

Methods: Newly diagnosed RA patients with a high disease activity and/or unfavourable prognostic factors, were treated according a treat-to-target regime. Initially, all patients were treated with methotrexate and prednisolone, for patients not achieving a good EULAR response after 13 weeks treatment was intensified. At baseline and after 13 and 26 weeks of treatment different measures were collected, including the ‘normality scale’ to measure the perception of normality (7 items, range 7-36, higher scores indicating higher feeling of normality), Disease Activity Score of 28 joints (DAS28), and remission. Remission was measured in two ways: 1) patient perceived remission using the question “Would you say that, at this moment, your disease activity is as good as gone? (yes/no)”; and 2) ACR/EULAR Boolean-based definition of remission.

Results: Forty-seven patients completed all assessments, of whom 34 (72%) were female with a mean ± SD age of 50 ± 14 years. At baseline, mean ± SD DAS28 was 4.5 ± 1.1 and the normality score was 20 ± 7. After 13 weeks of therapy, DAS28 significantly decreased to 2.5 ± 1.0 (p<0.001), and further to 2.2 ± 0.7 after 26 weeks (p<0.001). The feeling of normality was significantly increased  to 23 ± 8 in week 13 (p=0.001) and 24 ± 8 in week 26 (p<0.001) compared to baseline. As shown in Figure 1, patients in self-perceived remission had a significantly higher feeling of normality at week 13 (p<0.001) and week 26 (p=0.007) compared to patients not in self-perceived remission, while patients in Boolean remission had only a significantly higher feeling of normality at week 26 (p<0.001) compared to patients not in Boolean remission.

Conclusion: Self-perceived remission is significantly associated with higher normality perceptions after 13 and 26 weeks of therapy; Boolean remission only after 26 weeks of therapy. The normality scale has the ability to discriminate between patients in and not in remission.

References: [1] Felson et al. Arthritis & Rheum 2011; [2] Van Tuyl et al. J Rheumatol 2016; [3] Van Tuyl et al. ARD 2015; [4] Sanderson. Doctoral thesis 2009.

 


Disclosure: L. Rasch, None; M. Boers, None; W. F. Lems, None; S. Turk, None; D. van Schaardenburg, None; T. Sanderson, None; S. Hewlett, None; L. van Tuyl, None.

To cite this abstract in AMA style:

Rasch L, Boers M, Lems WF, Turk S, van Schaardenburg D, Sanderson T, Hewlett S, van Tuyl L. Back to Feeling Normal Again: Patients with Rheumatoid Arthritis in Remission [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/back-to-feeling-normal-again-patients-with-rheumatoid-arthritis-in-remission/. Accessed June 28, 2022.
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/back-to-feeling-normal-again-patients-with-rheumatoid-arthritis-in-remission/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2022 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies